Skip to content

5-MeO-DMT: all studies

Page 91 of 110: studies 901 to 910 of 1,097, newest first. Back to the 5-MeO-DMT overview

Research

Autonomic, Neuroendocrine, and Immunological Effects of Ayahuasca

Journal of Clinical Psychopharmacology October 15, 2011 Rafael G. Dos Santos, Marta Valle, José Carlos Bouso et al. 136 citations

Ayahuasca is an Amazonian psychotropic plant tea combining the 5-HT2A agonist N,N-dimethyltryptamine (DMT) and monoamine oxidase-inhibiting β-carboline alkaloids that render DMT orally active. The tea, obtained from Banisteriopsis caapi and Psychotria viridis, has traditionally been used for religious, ritual, and medicinal purposes by the indigenous peoples of the region. More recently, the...

DOI: 10.1097/jcp.0b013e31823607f6 (opens in new tab) Ayahuasca Hallucinogen Pharmacology Amphetamine +2

Tryptamines

Humana Press eBooks August 26, 2011 Javed Khan, Thomas J. Kennedy, Donnell R. Christian 2 citations

Natural and synthetic analogs of tryptamine are introduced as a class of hallucinogenic drugs derived from indole. The forensic identification of psilocin, psilocybin, bufotenin, 5-methoxy-N,N-dimethyltryptamine (5MeODMT), 5-methoxy-N,N-diisopropyltryptamine (5MeODIPT, aka foxy methoxy), N,N-diethyltryptamine (DET), and alpha-ethyltryptamine (AET) is discussed. Structural formulas are provided...

DOI: 10.1007/978-1-59745-437-7_15 (opens in new tab) Psilocybin Tryptamines Indole test Stereochemistry +2

Pharmacology of ayahuasca administered in two repeated doses

Psychopharmacology August 12, 2011 Rafael G. Dos Santos, Eva Grasa, Marta Valle et al. 139 citations

RationaleAyahuasca is an Amazonian tea containing the natural psychedelic 5-HT(2A/2C/1A) agonist N,N-dimethyltryptamine (DMT). It is used in ceremonial contexts for its visionary properties. The human pharmacology of ayahuasca has been well characterized following its administration in single doses.ObjectivesTo evaluate the human pharmacology of ayahuasca in repeated doses and assess the...

DOI: 10.1007/s00213-011-2434-x (opens in new tab) Ayahuasca Placebo Crossover study Pharmacology +3

Abuse Liability Profile of Three Substituted Tryptamines

Journal of Pharmacology and Experimental Therapeutics April 8, 2011 Michael B. Gatch, Michael J. Forster, Aaron Janowsky et al. 42 citations

The abuse liability profile of three synthetic hallucinogens, N,N-diisopropyltryptamine (DIPT), 5-N,N-diethyl-5-methoxytryptamine (5-MeO-DET), and 5-methoxy-α-methyltryptamine (5-MeO-AMT), was tested in rats trained to discriminate hallucinogenic and psychostimulant compounds, including cocaine, methamphetamine, 3,4-methylenedioxymethylamphetamine (MDMA), lysergic acid diethylamide (LSD),...

Alkaloid profiles of Mimosa tenuiflora and associated methods of analysis.

CABI eBooks 2011 Dale R. Gardner, Franklin Riet-Correa, Kip E. Panter 8 citations

The alkaloid contents of the leaves and seeds of M. tenuiflora collected from northeastern Brazil were studied. Alkaloids were isolated by classical acid/base extraction procedures and by cation exchange solid phase extraction. The crude alkaloid fractions were then analysed by thin layer chromatography (TLC), gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass...

Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice

Journal of Psychopharmacology December 8, 2010 Liselore Koedood, Adam L. Halberstadt, Susan B Powell et al. 212 citations

Psilocin (4-hydroxy- N, N-dimethyltryptamine) is a hallucinogen that acts as an agonist at 5-HT 1A , 5-HT 2A , and 5-HT 2C receptors. Psilocin is the active metabolite of psilocybin, a hallucinogen that is currently being investigated clinically as a potential therapeutic agent. In the present investigation, we used a combination of genetic and pharmacological approaches to identify the...

Characterization of the synthesis of N,N‐dimethyltryptamine by reductive amination using gas chromatography ion trap mass spectrometry

Drug Testing and Analysis July 1, 2010 Simon D. Brandt, Sharon A. Moore, Sally Freeman et al. 14 citations

The present study established an impurity profile of a synthetic route to the hallucinogenic N,N-dimethyltryptamine (DMT). The synthesis was carried out under reductive amination conditions between tryptamine and aqueous formaldehyde in the presence of acetic acid followed by reduction with sodium cyanoborohydride. Analytical characterization of this synthetic route was carried out by gas...

DOI: 10.1002/dta.142 (opens in new tab) Reductive amination Sodium cyanoborohydride Tryptamine Sodium borohydride +6

Assessment of addiction severity among ritual users of ayahuasca

Drug and Alcohol Dependence June 17, 2010 Josep María Fábregas, Débora González, Sabela Fondevila et al. 228 citations

Ayahuasca is a psychoactive beverage used for magico-religious purposes in the Amazon. Recently, Brazilian syncretic churches have helped spread the ritual use of ayahuasca abroad. This trend has raised concerns that regular use of this N,N-dimethyltryptamine-containing tea may lead to the medical and psychosocial problems typically associated with drugs of abuse. Here we assess potential drug...

Metabolism of designer drugs of abuse: an updated review.

Current Drug Metabolism June 1, 2010 Markus R Meyer, Hans H Maurer 112 citations

This paper reviews the metabolism of new designer drugs of abuse that have emerged on the black market during the last years and is an update of a review published in 2005. The presented review contains data concerning the so-called 2C compounds (phenethylamine type) such as 4-bromo-2,5-dimethoxy-beta-phenethylamine (2C-B), 4-iodo-2,5-dimethoxy-beta-phenethylamine (2C-I),...

DOI: 10.2174/138920010791526042 (opens in new tab) Full text (opens in new tab) Drug metabolism Pharmacokinetics Biotransformation Metabolites +19

Functional selectivity at the serotonin 2A receptor: differential signaling by serotonin and dimethylated tryptamines

The FASEB Journal April 1, 2010 Cullen L. Schmid, Laura M Bohn

Serotonin and the hallucinogenic metabolites of tryptamines, dimethylated tryptamines, activate the serotonin 2A receptor (5‐HT2AR), which is implicated in numerous mental health disorders. We have previously demonstrated that the 5‐HT2AR is differentially regulated by βarrestin2 (βarr2) depending upon the agonist; here we utilized βarr2 knockout mice to compare signaling profiles in vivo, by...